Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05178043
Title GT90001 Plus Nivolumab in Patients With Advanced Hepatocellular Carcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Suzhou Kintor Pharmaceutical Inc,
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.